NasdaqGS:ATEC

Stock Analysis Report

NOT FOR DISTRIBUTION
Header cover image

Executive Summary

Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders. More Details


Snowflake Analysis

Imperfect balance sheet with concerning outlook.


Similar Companies

Share Price & News

How has Alphatec Holdings's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: ATEC's share price has been volatile over the past 3 months.


Market Performance


7 Day Return

15.7%

ATEC

-1.7%

US Medical Equipment

-0.8%

US Market


1 Year Return

38.2%

ATEC

16.5%

US Medical Equipment

13.8%

US Market

Return vs Industry: ATEC exceeded the US Medical Equipment industry which returned 16.5% over the past year.

Return vs Market: ATEC exceeded the US Market which returned 13.8% over the past year.


Shareholder returns

ATECIndustryMarket
7 Day15.7%-1.7%-0.8%
30 Day15.9%-3.5%-5.7%
90 Day47.7%12.2%8.6%
1 Year38.2%38.2%17.5%16.5%16.4%13.8%
3 Year115.5%115.5%70.0%65.6%36.9%27.8%
5 Year79.1%79.1%139.5%121.3%85.0%64.2%

Price Volatility Vs. Market

How volatile is Alphatec Holdings's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Alphatec Holdings undervalued compared to its fair value and its price relative to the market?

23.54x

Price to Book (PB) ratio


Share Price vs. Fair Value

Below Fair Value: Insufficient data to calculate ATEC's fair value to establish if it is undervalued.

Significantly Below Fair Value: Insufficient data to calculate ATEC's fair value to establish if it is undervalued.


Price To Earnings Ratio

PE vs Industry: ATEC is unprofitable, so we can't compare its PE Ratio to the US Medical Equipment industry average.

PE vs Market: ATEC is unprofitable, so we can't compare its PE Ratio to the US market.


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate ATEC's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: ATEC is overvalued based on its PB Ratio (23.5x) compared to the US Medical Equipment industry average (3.9x).


Next Steps

Future Growth

How is Alphatec Holdings forecast to perform in the next 1 to 3 years based on estimates from 6 analysts?

49.6%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: ATEC is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: ATEC is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: ATEC is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: ATEC's revenue (16.9% per year) is forecast to grow faster than the US market (9.9% per year).

High Growth Revenue: ATEC's revenue (16.9% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if ATEC's Return on Equity is forecast to be high in 3 years time


Next Steps

Past Performance

How has Alphatec Holdings performed over the past 5 years?

22.4%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: ATEC is currently unprofitable.

Growing Profit Margin: ATEC is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: ATEC is unprofitable, but has reduced losses over the past 5 years at a rate of 22.4% per year.

Accelerating Growth: Unable to compare ATEC's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: ATEC is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (1.8%).


Return on Equity

High ROE: ATEC has a negative Return on Equity (-160.54%), as it is currently unprofitable.


Next Steps

Financial Health

How is Alphatec Holdings's financial position?


Financial Position Analysis

Short Term Liabilities: ATEC's short term assets ($96.0M) exceed its short term liabilities ($42.8M).

Long Term Liabilities: ATEC's short term assets ($96.0M) exceed its long term liabilities ($75.9M).


Debt to Equity History and Analysis

Debt Level: ATEC's debt to equity ratio (156.5%) is considered high.

Reducing Debt: ATEC's debt to equity ratio has increased from 48.9% to 156.5% over the past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: ATEC has less than a year of cash runway based on its current free cash flow.

Forecast Cash Runway: ATEC has less than a year of cash runway if free cash flow continues to reduce at historical rates of 23.8% each year


Next Steps

Dividend

What is Alphatec Holdings's current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate ATEC's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate ATEC's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if ATEC's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if ATEC's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of ATEC's dividend in 3 years as they are not forecast to pay a notable one for the US market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

2.5yrs

Average management tenure


CEO

Pat Miles (54 yo)

2.5yrs

Tenure

US$7,960,105

Compensation

Mr. Patrick S. Miles, also known as Pat, has been an Executive Chairman of Alphatec Holdings, Inc since October 1, 2017 and its Chief Executive Officer since March 06, 2018 and also serves as its President ...


CEO Compensation Analysis

Compensation vs Market: Pat's total compensation ($USD7.96M) is above average for companies of similar size in the US market ($USD2.02M).

Compensation vs Earnings: Pat's compensation has increased whilst the company is unprofitable.


Leadership Team

NamePositionTenureCompensationOwnership
Patrick Miles
Executive Chairman2.5yrsUS$7.96m3.86%
$ 17.2m
Jeffrey Black
Executive VP & CFO3.5yrsUS$1.94m0.28%
$ 1.2m
David Sponsel
Executive Vice President of Sales1.42yrsUS$2.06m0.12%
$ 532.8k
Craig Hunsaker
Executive VP of People & Culture3.5yrsUS$1.00m0.81%
$ 3.6m
Brian Snider
Executive Vice President of Marketing & Development3.5yrsno data1.0%
$ 4.4m
Jonathan Allen
Executive Vice President of Commercial Operations3.75yrsno datano data
Luiz Pimenta
Chief Medical Officer2.5yrsno datano data
Kelli Howell
Executive Vice President of Clinical Strategies2.5yrsno data0.24%
$ 1.1m
Mark Ojeda
Executive Vice President of Cervical & Biologics2yrsno datano data
Eric Dasso
Executive Vice President of Adjunctive Technologies1.08yrsno datano data
Robert Judd
VP of Finance & Controller2.08yrsno datano data

2.5yrs

Average Tenure

50yo

Average Age

Experienced Management: ATEC's management team is considered experienced (2.5 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Patrick Miles
Executive Chairman2.5yrsUS$7.96m3.86%
$ 17.2m
Ward Woods
Independent Director2.92yrsUS$117.79k1.86%
$ 8.3m
Mortimer Berkowitz
Independent Lead Director2.92yrsno data1.04%
$ 4.6m
Stephen Hochschuler
Chairman of Scientific Advisory Board14.92yrsUS$42.42kno data
James Yue
Member of Scientific Advisory Boardno datano datano data
Frank Phillips
Member of Scientific Advisory Boardno datano datano data
Frank Eismont
Member of Scientific Advisory Boardno datano datano data
Bret Abshire
Member of Scientific Advisory Board14yrsno datano data
Frank Cammisa
Member of Scientific Advisory Board13.25yrsno datano data
J. Johnson
Member of Scientific Advisory Board13.58yrsno datano data
Donald Williams
Independent Director5.42yrsUS$124.04k0.15%
$ 677.0k
Quentin Blackford
Independent Director2.92yrsUS$116.54k0.78%
$ 3.5m

5.4yrs

Average Tenure

64yo

Average Age

Experienced Board: ATEC's board of directors are considered experienced (5.4 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: ATEC insiders have only sold shares in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 6.8%.


Top Shareholders

Company Information

Alphatec Holdings, Inc.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Alphatec Holdings, Inc.
  • Ticker: ATEC
  • Exchange: NasdaqGS
  • Founded: 1990
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Market Cap: US$446.261m
  • Shares outstanding: 64.30m
  • Website: https://www.atecspine.com

Number of Employees


Location

  • Alphatec Holdings, Inc.
  • 5818 El Camino Real
  • Carlsbad
  • California
  • 92008
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
ATECNasdaqGS (Nasdaq Global Select)YesCommon SharesUSUSDJun 2006
L1Z1DB (Deutsche Boerse AG)YesCommon SharesDEEURJun 2006

Biography

Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders. The company offers SafeOp Neural InformatiX System, an Al ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2020/09/28 04:44
End of Day Share Price2020/09/25 00:00
Earnings2020/06/30
Annual Earnings2019/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.